// App-Quantinova.ai

4362 : T cell repertoire diversification is associated with immune related toxicities following immune checkpoint inhibition in metastatic cancer patients

Researchers

Presenter

  • David Y. Oh

Principal Investigators

  • Jason Cham

  • Li Zhang

  • Grant Fong

  • Mark Klinger

  • Malek Faham

  • Lawrence Fong

Medical Centers

  • University of California, San Francisco, San Francisco, CA

  • Adaptive Biotechnologies, South San Francisco, CA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • Cluster of Differentiation 4

  • Cluster of differentiation 8A

  • Cytotoxic T-lymphocyte-associated protein 4

  • T-cell receptor

Drug/Treatment

  • Ipilimumab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved